To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.
Taxation119-hr7693 — To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.. Sponsored by Rep. Gottheimer, Josh [D-NJ-5]. Introduced 2026-02-25. House bill. 119th Congress. Latest action: Referred to the House Committee on Energy and Commerce.
- Sponsor
- Rep. Gottheimer, Josh [D-NJ-5] (D), NJ
- Introduced
- 2026-02-25
- Committees
- Energy and Commerce Committee
- Latest Action
- Referred to the House Committee on Energy and Commerce.
No roll-call vote data available for this bill.
Similar Bills
- 119-hr2436 — To amend the Internal Revenue Code of 1986 to treat distributions from health savings accounts for funeral expenses of the account beneficiary as qualified distributions. 97% match
- 119-hr7681 — To amend the Internal Revenue Code of 1986 to expand eligibility for health savings accounts, and for other purposes. 34% match
- 119-s2206 — A bill to amend the Internal Revenue Code of 1986 to increase the limitation on distributions from 529 accounts for qualified higher education expenses. 33% match
- 119-hr3186 — To amend the Internal Revenue Code of 1986 to create Universal Savings Accounts. 32% match
- 118-hr8438 — To amend the Internal Revenue Code of 1986 to permit qualified distributions from section 529 plans for certain transportation and parking expenses. 31% match 118th Congress
Investigate this bill →
Beneficiary scoring, topic classification, and fiscal analysis